A detailed history of Assetmark, Inc transactions in Novartis Ag stock. As of the latest transaction made, Assetmark, Inc holds 223,996 shares of NVS stock, worth $23.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
223,996
Previous 213,706 4.82%
Holding current value
$23.1 Million
Previous $22.8 Million 13.24%
% of portfolio
0.07%
Previous 0.07%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$106.13 - $120.89 $1.09 Million - $1.24 Million
10,290 Added 4.82%
223,996 $25.8 Million
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $462,016 - $535,883
-4,991 Reduced 2.28%
213,706 $22.8 Million
Q1 2024

May 06, 2024

BUY
$95.27 - $108.47 $228,457 - $260,111
2,398 Added 1.11%
218,697 $21.2 Million
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $1.2 Million - $1.32 Million
13,006 Added 6.4%
216,299 $21.8 Million
Q3 2023

Oct 27, 2023

BUY
$94.73 - $105.13 $428,558 - $475,608
4,524 Added 2.28%
203,293 $20.7 Million
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $1.02 Million - $1.15 Million
10,975 Added 5.84%
198,769 $20.1 Million
Q1 2023

May 05, 2023

BUY
$80.03 - $92.81 $32,252 - $37,402
403 Added 0.22%
187,794 $17.3 Million
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $188,799 - $231,207
2,499 Added 1.35%
187,391 $17 Million
Q3 2022

Nov 01, 2022

BUY
$74.61 - $87.26 $985,896 - $1.15 Million
13,214 Added 7.7%
184,892 $14.1 Million
Q2 2022

Aug 03, 2022

BUY
$80.52 - $93.75 $1.4 Million - $1.63 Million
17,380 Added 11.26%
171,678 $14.5 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $11.5 Million - $13 Million
143,165 Added 1285.95%
154,298 $13.5 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $433,249 - $479,074
5,436 Added 95.42%
11,133 $974,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $60,517 - $70,403
740 Added 14.93%
5,697 $466,000
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $3,835 - $4,236
45 Added 0.92%
4,957 $452,000
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $18,203 - $21,466
218 Added 4.64%
4,912 $420,000
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $48,793 - $59,018
-625 Reduced 11.75%
4,694 $443,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $168,058 - $186,186
-2,046 Reduced 27.78%
5,319 $463,000
Q2 2020

Aug 11, 2020

SELL
$80.93 - $91.1 $129,407 - $145,668
-1,599 Reduced 17.84%
7,365 $643,000
Q1 2020

May 12, 2020

BUY
$70.67 - $99.01 $23,109 - $32,376
327 Added 3.79%
8,964 $739,000
Q4 2019

Feb 11, 2020

SELL
$84.35 - $95.37 $79,626 - $90,029
-944 Reduced 9.85%
8,637 $818,000
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $273,642 - $301,537
3,199 Added 50.13%
9,581 $833,000
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $76,003 - $93,542
1,008 Added 18.76%
6,382 $583,000
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $26,663 - $30,497
354 Added 7.05%
5,374 $517,000
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $4,787 - $5,331
65 Added 1.31%
5,020 $431,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $34,808 - $40,263
520 Added 11.72%
4,955 $427,000
Q2 2018

Aug 01, 2018

BUY
$64.91 - $73.36 $36,609 - $41,375
564 Added 14.57%
4,435 $335,000
Q1 2018

May 16, 2018

BUY
$70.39 - $84.15 $107,344 - $128,328
1,525 Added 65.0%
3,871 $313,000
Q4 2017

Feb 13, 2018

BUY
$72.33 - $77.64 $24,881 - $26,708
344 Added 17.18%
2,346 $197,000
Q3 2017

Nov 08, 2017

SELL
$74.14 - $77.27 $6.8 Million - $7.09 Million
-91,775 Reduced 97.87%
2,002 $172,000
Q2 2017

Aug 15, 2017

BUY
N/A
455 Added 0.49%
93,777 $7.83 Million
Q1 2017

Sep 15, 2017

BUY
N/A
11,666 Added 14.29%
93,322 $6.93 Million
Q4 2016

Sep 15, 2017

BUY
N/A
2,965 Added 3.77%
81,656 $5.95 Million
Q3 2016

Sep 15, 2017

SELL
N/A
-19,622 Reduced 19.96%
78,691 $6.21 Million
Q2 2016

Sep 15, 2017

BUY
N/A
3,621 Added 3.82%
98,313 $8.11 Million
Q1 2016

Sep 15, 2017

BUY
N/A
20,060 Added 26.88%
94,692 $6.86 Million
Q4 2015

Sep 15, 2017

BUY
N/A
74,632
74,632 $6.42 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.